0002060755-26-000027.txt : 20260521 0002060755-26-000027.hdr.sgml : 20260521 20260521171141 ACCESSION NUMBER: 0002060755-26-000027 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260521 DATE AS OF CHANGE: 20260521 EFFECTIVENESS DATE: 20260521 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Conexeu Sciences Inc. CENTRAL INDEX KEY: 0002066836 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 000000000 STATE OF INCORPORATION: NV FISCAL YEAR END: 1031 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-584842 FILM NUMBER: 261009839 BUSINESS ADDRESS: STREET 1: 50 WEST LIBERTY STREET, SUITE 880 CITY: RENO STATE: NV ZIP: 89501 BUSINESS PHONE: 604-315-4722 MAIL ADDRESS: STREET 1: 50 WEST LIBERTY STREET, SUITE 880 CITY: RENO STATE: NV ZIP: 89501 D 1 primary_doc.xml X0708 D LIVE 0002066836 Conexeu Sciences Inc. 50 WEST LIBERTY STREET, SUITE 880 RENO NV NEVADA 89501 604-315-4722 NEVADA None None Corporation true 2022 DAVID R BOGART 50 WEST LIBERTY STREET, SUITE 880 RENO NV NEVADA 89501 Director MILES HARRISON 50 WEST LIBERTY STREET, SUITE 880 RENO NV NEVADA 89501 Executive Officer Director AARON FARBERG 50 WEST LIBERTY STREET, SUITE 880 RENO NV NEVADA 89501 Director STEPHEN D INOUYE 50 WEST LIBERTY STREET, SUITE 880 RENO NV NEVADA 89501 Executive Officer CLAUDIA CHAVEZ-MUNOZ 50 WEST LIBERTY STREET, SUITE 880 RENO NV NEVADA 89501 Executive Officer JEFF SHARPE 50 WEST LIBERTY STREET, SUITE 880 RENO NV NEVADA 89501 Director Z PAUL LORENC 50 WEST LIBERTY STREET, SUITE 880 RENO NV NEVADA 89501 Director SEBASTIAN PURCELL 50 WEST LIBERTY STREET, SUITE 880 RENO NV NEVADA 89501 Director BRIAN PILCHER 50 WEST LIBERTY STREET, SUITE 880 RENO NV NEVADA 89501 Executive Officer Biotechnology Decline to Disclose 06b false 2026-05-12 true true true false 0 1248634 543 1248091 Total Offering Amount represents the aggregated price of 542,648 warrants and the aggregated exercise price of these warrants exercisable at $2.30 per share until May 12, 2029. There is no guarantee that the warrants will be exercised. false 3 0 0 0 false Conexeu Sciences Inc. /s/ Stephen Inouye Stephen Inouye CFO 2026-05-21